about
Immunopharmacotherapy of non-infectious uveitis: where do we stand?Understanding autoimmunity in the eye: from animal models to novel therapies.A novel bispecific molecule delivered by recombinant AAV2 suppresses ocular inflammation and choroidal neovascularizationNew pharmacotherapy options for noninfectious posterior uveitis.Proteomic Profiling Analysis Reveals a Link between Experimental Autoimmune Uveitis and Complement Activation in Rats.
P2860
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Emerging drugs for the treatment of uveitis.
@en
type
label
Emerging drugs for the treatment of uveitis.
@en
prefLabel
Emerging drugs for the treatment of uveitis.
@en
P2860
P1476
Emerging drugs for the treatment of uveitis.
@en
P2093
Jennifer E Thorne
Theresa G Leung
P2860
P304
P356
10.1517/14728214.2013.861417
P407
P577
2013-12-01T00:00:00Z